LEN
50
-2
O
17
-13
FAST
57
-3
SCHW
62
-2
MU
28
-3
NWSA
62
-7
AAPL
40
-6
MAR
63
-5
DHR
32
-6
BDX
56
10
MCD
52
-5
NEE
54
7
HAL
48
-3
ROST
57
-3
CAT
59
-2
PSA
56
3
MSI
72
-3
RHI
57
-6
FOX
51
-6
EXR
57
2
LEN
50
-2
O
17
-13
FAST
57
-3
SCHW
62
-2
MU
28
-3
NWSA
62
-7
AAPL
40
-6
MAR
63
-5
DHR
32
-6
BDX
56
10
MCD
52
-5
NEE
54
7
HAL
48
-3
ROST
57
-3
CAT
59
-2
PSA
56
3
MSI
72
-3
RHI
57
-6
FOX
51
-6
EXR
57
2
Financhill
Back

SPDR® MSCI EAFE Fssl Ful Free RsrvETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
66

EFAX
SPDR® MSCI EAFE Fssl Ful Free RsrvETF

Last Price:
40.33
Seasonality Move:
3.63%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
66
SPDR® MSCI EAFE Fssl Ful Free RsrvETF (EFAX) is a Buy

Is SPDR® MSCI EAFE Fssl Ful Free RsrvETF a Buy, Sell or Hold?

  • The current SPDR® MSCI EAFE Fssl Ful Free RsrvETF [EFAX] share price is $40.39. The Score for EFAX is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
  • EFAX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EFAX Stock Price Chart

What is SPDR® MSCI EAFE Fssl Ful Free RsrvETF's stock price today?

  • The SPDR® MSCI EAFE Fssl Ful Free RsrvETF share price today is $40.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EFAX is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

EFAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 33.03 Sell
Chaikin Money Flow: -1109 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.11 - 42.59) Sell
Bollinger Bands (100): (41.04 - 43.08) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

EFAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.08 Sell
20-day SMA: 41.6 Sell
50-day SMA: 42.45 Sell
200-day SMA: 41.44 Sell
8-day EMA: 40.95 Sell
20-day EMA: 41.52 Sell
50-day EMA: 42.01 Sell
200-day EMA: 41.16 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

SPDR® MSCI EAFE Fssl Ful Free RsrvETF Earnings Growth & EFAX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

SPDR® MSCI EAFE Fssl Ful Free RsrvETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):